  | SALVATO, I.* , KLEIN, E.* , POLI, A., Rezaeipour, M., Ermini, L., Nosirov, B., Lipsa, A., Oudin, A., Baus, V., Dore, G. M., COSMA, A., GOLEBIEWSKA, A., MARCHINI, A.* , & NICLOU, S. P.*. (2024). Adenoviral delivery of the CIITA transgene induces T-cell-mediated killing in glioblastoma organoids. Molecular Oncology. doi:10.1002/1878-0261.13750  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Oudin, A., Moreno-Sanchez, P. M., Baus, V., NICLOU, S. P., & GOLEBIEWSKA, A. (02 January 2024). Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence. BMC Cancer, 24 (1), 3. doi:10.1186/s12885-023-11774-6 Peer Reviewed verified by ORBi |
Yabo, Y. A., Moreno-Sanchez, P. M., Pires-Afonso, Y., Kaoma, T., Nosirov, B., Scafidi, A., Ermini, L., Lipsa, A., Oudin, A., KYRIAKIS, D., GRZYB, K., POOVATHINGAL, S. K., Poli, A., Muller, A., TOTH, R., KLINK, B., BERCHEM, G. J. M. J., Berthold, C., HERTEL, F., ... GOLEBIEWSKA, A. (2023). Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/60199. doi:10.1101/2023.03.05.531162 |
 | Biswas, A., Salvucci, M., Connor, K., Düssmann, H., Carberry, S., Fichtner, M., King, E., Murphy, B., O'Farrell, A. C., Cryan, J., Beausang, A., Heffernan, J., Cremona, M., Hennessy, B. T., Clerkin, J., Sweeney, K. J., MacNally, S., Brett, F., O'Halloran, P., ... Prehn, J. H. M. (June 2023). Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors. Journal of Neuro-Oncology, 163 (2), 327-338. doi:10.1007/s11060-023-04341-3 Peer Reviewed verified by ORBi |
 | NICLOU, S. P., & GOLEBIEWSKA, A. (February 2023). How to move a “fried egg”: membrane blebbing in oligodendrogliomas. Neuro-Oncology, 25 (6), 1044–1046. doi:10.1093/neuonc/noad039 Peer Reviewed verified by ORBi |
  | Pires-Afonso, Y., Muller, A., GRZYB, K., Oudin, A., Yabo, Y. A., SOUSA, C., Scafidi, A., Poli, A., COSMA, A., HALDER, R., COOWAR, D., GOLEBIEWSKA, A., SKUPIN, A., NICLOU, S. P., & MICHELUCCI, A. (September 2022). Elucidating tumour-associated microglia/macrophage diversity along glioblastoma progression and under ACOD1 deficiency. Molecular Oncology, 16 (17), 3167 - 3191. doi:10.1002/1878-0261.13287 Peer Reviewed verified by ORBi |
 | Venkataramani, V., Yang, Y., Schubert, M. C., Reyhan, E., Tetzlaff, S. K., Wißmann, N., Botz, M., Soyka, S. J., Beretta, C. A., Pramatarov, R. L., Fankhauser, L., Garofano, L., Freudenberg, A., Wagner, J., Tanev, D. I., Ratliff, M., Xie, R., Kessler, T., Hoffmann, D. C., ... Winkler, F. (04 August 2022). Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell, 185 (16), 2899-2917.e31. doi:10.1016/j.cell.2022.06.054 Peer Reviewed verified by ORBi |
 | ILINA, E., CIALINI, C., GERLOFF, D., Duarte Garcia-Escudero, M., Jeanty, C., Thézénas, M.-L., Lesur, A., Puard, V., Bernardin, F., Moter, A., Schuster, A., Dieterle, M., GOLEBIEWSKA, A., GERARDY, J.-J., DITTMAR, G., NICLOU, S. P., Müller, T., & MITTELBRONN, M. (18 February 2022). Enzymatic activity of glycosyltransferase GLT8D1 promotes human glioblastoma cell migration. iScience, 25 (2), 103842. doi:10.1016/j.isci.2022.103842 Peer Reviewed verified by ORBi |
 | Yabo, Y. A., NICLOU, S. P., & GOLEBIEWSKA, A. (December 2021). Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma. Neuro-Oncology, 24 (5), 669–682. doi:10.1093/neuonc/noab269 Peer Reviewed verified by ORBi |
 | Kulkarni, A., Ferreira, T., Bretscher, C., Grewenig, A., El-Andaloussi, N., Bonifati, S., Marttila, T., PALISSOT, V., Hossain, J. A., AZUAJE, F., Miletic, H., Ystaas, L. A. R., GOLEBIEWSKA, A., NICLOU, S. P., Roeth, R., Niesler, B., Weiss, A., Brino, L., & MARCHINI, A. (22 June 2021). Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry. Nature Communications, 12 (1), 3834. doi:10.1038/s41467-021-24034-7 Peer Reviewed verified by ORBi |
 | Oudin, A., Baus, V., Barthelemy, V., Fabian, C., KLEIN, E., Dieterle, M., Wantz, M., Hau, A.-C., DORDING, C., Bernard, A., MICHELUCCI, A., Yabo, Y. A., Kanli, G., Keunen, O., Bjerkvig, R., NICLOU, S. P., & GOLEBIEWSKA, A. (18 June 2021). Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors. STAR Protocols, 2 (2), 100534. doi:10.1016/j.xpro.2021.100534 Peer Reviewed verified by ORBi |
 | NICLOU, S. P., & GOLEBIEWSKA, A. (April 2021). Turning strength into weakness: protein degradation and autophagy as therapeutic targets in glioblastoma? Neuro-Oncology, 23 (7), 1041–1043. doi:10.1093/neuonc/noab099 Peer Reviewed verified by ORBi |
 | Schuster, A., KLEIN, E., Neirinckx, V., Knudsen, A. M., Fabian, C., Hau, A.-C., Dieterle, M., Oudin, A., NAZAROV, P., GOLEBIEWSKA, A., Muller, A., Perez-Hernandez, D., Rodius, S., DITTMAR, G., Bjerkvig, R., Herold-Mende, C., KLINK, B., Kristensen, B. W., & NICLOU, S. P. (11 December 2020). AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nature Communications, 11 (1), 6366. doi:10.1038/s41467-020-20029-y Peer Reviewed verified by ORBi |
 | White, K., Connor, K., Clerkin, J., Murphy, B. M., Salvucci, M., O'Farrell, A. C., REHM, M., O'Brien, D., Prehn, J. H. M., NICLOU, S. P., Lamfers, M. L. M., Verreault, M., Idbaih, A., Verhaak, R., GOLEBIEWSKA, A., & Byrne, A. T. (December 2020). New hints towards a precision medicine strategy for IDH wild-type glioblastoma. Annals of Oncology, 31 (12), 1679-1692. doi:10.1016/j.annonc.2020.08.2336 Peer Reviewed verified by ORBi |
 | GOLEBIEWSKA, A., Hau, A.-C., Oudin, A., Stieber, D., Yabo, Y. A., Baus, V., Barthelemy, V., Klein, E., Bougnaud, S., Keunen, O., Wantz, M., MICHELUCCI, A., Neirinckx, V., Muller, A., Kaoma, T., Nazarov, P. V., AZUAJE, F., De Falco, A., Flies, B., ... NICLOU, S. (2020). Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathologica. doi:10.1007/s00401-020-02226-7 Peer Reviewed verified by ORBi |
 | FRITAH, S., Muller, A., Jiang, W., Mitra, R., Sarmini, M., Dieterle, M., GOLEBIEWSKA, A., Ye, T., Van Dyck, E., Herold-Mende, C., Zhao, Z., AZUAJE, F., & NICLOU, S. P. (10 September 2020). Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma. Cancers, 12 (9). doi:10.3390/cancers12092583 Peer Reviewed verified by ORBi |
 | GOLEBIEWSKA, A., Hau, A.-C., Oudin, A., Stieber, D., Yabo, Y. A., Baus, V., Barthelemy, V., Klein, E., Bougnaud, S., Keunen, O., Wantz, M., MICHELUCCI, A., Neirinckx, V., Muller, A., Kaoma, T., Nazarov, P. V., AZUAJE, F., De Falco, A., Flies, B., ... NICLOU, S. (2020). Primary and recurrent glioma patient-derived orthotopic xenografts (PDOX) represent relevant patient avatars for precision medicine. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/43022. doi:10.1101/2020.04.24.057802 |
 | KLEIN, E., Hau, A.-C., Oudin, A., GOLEBIEWSKA, A., & NICLOU, S. P. (2020). Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy. Frontiers in Oncology, 10, 604121. doi:10.3389/fonc.2020.604121 Peer Reviewed verified by ORBi |
 | Zeiner, P. S., Preusse, C., GOLEBIEWSKA, A., Zinke, J., Iriondo, A., Muller, A., Kaoma, T., Filipski, K., Müller-Eschner, M., Bernatz, S., Blank, A.-E., Baumgarten, P., ILINA, E., Grote, A., Hansmann, M. L., Verhoff, M. A., Franz, K., Feuerhake, F., Steinbach, J. P., ... MITTELBRONN, M. (July 2019). Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas. Brain Pathology, 29 (4), 513-529. doi:10.1111/bpa.12690 Peer Reviewed verified by ORBi |
 | Schuster, A., Erasimus, H. L. N., FRITAH, S., Nazarov, P., van Dyck, E., NICLOU, S. P., & GOLEBIEWSKA, A. (January 2019). RNAi/CRISPR Screens: from a Pool to a Valid Hit. Trends in Biotechnology, 37 (1), 38–55. doi:10.1016/j.tibtech.2018.08.002 Peer Reviewed verified by ORBi |
 | Dudvarski Stanković, N., Bicker, F., Keller, S., Jones, D. T., Harter, P. N., Kienzle, A., Gillmann, C., Arnold, P., GOLEBIEWSKA, A., Keunen, O., Giese, A., von Deimling, A., Bäuerle, T., NICLOU, S. P., MITTELBRONN, M., Ye, W., Pfister, S. M., & Schmidt, M. H. (September 2018). EGFL7 enhances surface expression of integrin α(5)β(1) to promote angiogenesis in malignant brain tumors. EMBO Molecular Medicine, 10 (9). doi:10.15252/emmm.201708420 Peer Reviewed verified by ORBi |
 | AZUAJE, F., Kaoma, T., Jeanty, C., NAZAROV, P., Muller, A., Kim, S.-Y., DITTMAR, G., GOLEBIEWSKA, A., & NICLOU, S. P. (2018). Hub genes in a pan-cancer co-expression network show potential for predicting drug responses. F1000Research, 7, 1906. doi:10.12688/f1000research.17149.2 Peer Reviewed verified by ORBi |
 | Fack, F., Tardito, S., Hochart, G., Oudin, A., Zheng, L., FRITAH, S., GOLEBIEWSKA, A., Nazarov, P., Bernard, A., Hau, A.-C., Keunen, O., Leenders, W., Lund-Johansen, M., Stauber, J., Gottlieb, E., Bjerkvig, R., & NICLOU, S. P. (October 2017). Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways. EMBO Molecular Medicine, 9 (12), 1681–1695. doi:10.15252/emmm.201707729 Peer Reviewed verified by ORBi |
 | Abdul Rahim, S. A., Dirkse, A., Oudin, A., Schuster, A., BOHLER, J., Barthelemy, V., Muller, A., Vallar, L., JANJI, B., GOLEBIEWSKA, A., & NICLOU, S. P. (05 September 2017). Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A. British Journal of Cancer, 117 (6), 813-825. doi:10.1038/bjc.2017.263 Peer Reviewed verified by ORBi |
 | Bougnaud, S., GOLEBIEWSKA, A., Oudin, A., Keunen, O., Harter, P. N., Mäder, L., AZUAJE, F., FRITAH, S., Stieber, D., Kaoma, T., Vallar, L., Brons, N. H. C., Daubon, T., Miletic, H., Sundstrøm, T., Herold-Mende, C., MITTELBRONN, M., Bjerkvig, R., & NICLOU, S. P. (31 May 2016). Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma. Oncotarget, 7 (22), 31955 - 31971. doi:10.18632/oncotarget.7454 Peer Reviewed verified by ORBi |
 | Demeure, K., Fack, F., DURIEZ, E., Tiemann, K., Bernard, A., GOLEBIEWSKA, A., Bougnaud, S., Bjerkvig, R., Domon, B., & NICLOU, S. P. (February 2016). Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM). Molecular and Cellular Proteomics, 15 (2), 481-92. doi:10.1074/mcp.M115.052423 Peer Reviewed verified by ORBi |
Burtey, A., Wagner, M., Hodneland, E., Skaftnesmo, K. O., Schoelermann, J., Mondragon, I. R., Espedal, H., GOLEBIEWSKA, A., NICLOU, S. P., Bjerkvig, R., Kögel, T., & Gerdes, H.-H. (November 2015). Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes. FASEB Journal, 29 (11), 4695-712. doi:10.1096/fj.14-268615 Peer Reviewed verified by ORBi |
 | Fack, F., Espedal, H., Keunen, O., GOLEBIEWSKA, A., Obad, N., Harter, P. N., MITTELBRONN, M., Bähr, O., Weyerbrock, A., Stuhr, L., Miletic, H., Sakariassen, P. Ø., Stieber, D., Rygh, C. B., Lund-Johansen, M., Zheng, L., Gottlieb, E., NICLOU, S. P., & Bjerkvig, R. (January 2015). Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas. Acta Neuropathologica, 129 (1), 115-31. doi:10.1007/s00401-014-1352-5 Peer Reviewed verified by ORBi |
 | Sanzey, M., Abdul Rahim, S. A., Oudin, A., Dirkse, A., Kaoma, T., Vallar, L., Herold-Mende, C., Bjerkvig, R., GOLEBIEWSKA, A., & NICLOU, S. P. (2015). Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma. PLoS ONE, 10 (5), 0123544. doi:10.1371/journal.pone.0123544 Peer Reviewed verified by ORBi |
 | Torsvik, A., Stieber, D., Enger, P. Ø., GOLEBIEWSKA, A., Molven, A., Svendsen, A., Westermark, B., NICLOU, S. P., Olsen, T. K., Chekenya Enger, M., & Bjerkvig, R. (August 2014). U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Medicine, 3 (4), 812-24. doi:10.1002/cam4.219 Peer Reviewed verified by ORBi |
 | Johansson, M., Oudin, A., Tiemann, K., Bernard, A., GOLEBIEWSKA, A., Keunen, O., Fack, F., Stieber, D., Wang, B., Hedman, H., & NICLOU, S. P. (September 2013). The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status. Neuro-Oncology, 15 (9), 1200-11. doi:10.1093/neuonc/not054 Peer Reviewed verified by ORBi |
 | GOLEBIEWSKA, A., Brons, N. H. C., Bjerkvig, R., & NICLOU, S. P. (04 February 2011). Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell, 8 (2), 136-47. doi:10.1016/j.stem.2011.01.007 Peer Reviewed verified by ORBi |
Dataset: